Owen Raszkiewicz | December 5, 2014 7:58am
More »
Mike King | July 8, 2014 4:29pm
More »
Mike King | June 24, 2014 2:33pm
More »
About Bionomics Ltd (ASX: BNO)
Bionomics Ltd is a global, clinical-stage biopharmaceutical company. It is primarily engaged in the development of therapeutics for diseases of the central nervous system and cancer. The company's reportable segment is the Drug Discovery and Development segment which is engaged in the discovery, development, and commercialization of compounds to match a target product profile. The company generates all of its revenues from Australia.
Share Price History
Data provided by Morningstar.
Date |
Close |
Change |
% Change |
Volume |
Open |
High |
Low |
15 Jan 2021 |
$0.16 |
$0.01 |
6.45% |
1,435,115 |
$0.16 |
$0.17 |
$0.16 |
14 Jan 2021 |
$0.16 |
$0.01 |
6.67% |
715,774 |
$0.16 |
$0.16 |
$0.15 |
13 Jan 2021 |
$0.15 |
$0.00 |
0.00% |
297,133 |
$0.15 |
$0.16 |
$0.15 |
12 Jan 2021 |
$0.15 |
$0.00 |
0.00% |
270,923 |
$0.15 |
$0.15 |
$0.14 |
11 Jan 2021 |
$0.15 |
$0.01 |
6.90% |
53,221 |
$0.15 |
$0.15 |
$0.15 |
08 Jan 2021 |
$0.15 |
$-0.01 |
-6.67% |
80,343 |
$0.15 |
$0.15 |
$0.14 |
07 Jan 2021 |
$0.15 |
$0.00 |
0.00% |
78,942 |
$0.15 |
$0.15 |
$0.15 |
06 Jan 2021 |
$0.15 |
$-0.01 |
-6.45% |
220,097 |
$0.15 |
$0.16 |
$0.15 |
05 Jan 2021 |
$0.16 |
$0.01 |
6.67% |
304,693 |
$0.15 |
$0.16 |
$0.15 |
04 Jan 2021 |
$0.15 |
$0.01 |
6.90% |
162,498 |
$0.15 |
$0.15 |
$0.15 |
31 Dec 2020 |
$0.15 |
$0.00 |
0.00% |
88,159 |
$0.15 |
$0.15 |
$0.15 |
30 Dec 2020 |
$0.15 |
$0.00 |
0.00% |
153,284 |
$0.15 |
$0.15 |
$0.15 |
29 Dec 2020 |
$0.15 |
$-0.01 |
-6.67% |
82,819 |
$0.15 |
$0.15 |
$0.14 |
24 Dec 2020 |
$0.15 |
$0.00 |
0.00% |
172,489 |
$0.15 |
$0.15 |
$0.14 |
23 Dec 2020 |
$0.15 |
$-0.01 |
-6.45% |
388,364 |
$0.16 |
$0.16 |
$0.15 |
22 Dec 2020 |
$0.16 |
$0.01 |
6.67% |
492,529 |
$0.15 |
$0.16 |
$0.15 |
21 Dec 2020 |
$0.15 |
$0.01 |
7.14% |
814,134 |
$0.15 |
$0.15 |
$0.15 |
18 Dec 2020 |
$0.14 |
$0.01 |
7.41% |
1,042,493 |
$0.15 |
$0.15 |
$0.13 |
Show more
Director Transactions
Data provided by Morningstar.
Date |
Director |
Type |
Amount |
Value |
Notes |
23 Nov 2020 |
Jane Ryan |
Issued |
500 |
$62,500 |
|
22 Oct 2020 |
Peter Turner |
Issued |
15 |
$638 |
|
22 Oct 2020 |
David Wilson |
Issued |
15 |
$638 |
|
22 Oct 2020 |
David Wilson |
Transfer |
200 |
$26,000 |
|
22 Oct 2020 |
David Wilson |
Transfer |
200 |
$26,000 |
|
28 Aug 2020 |
Errol De Souza |
Issued |
12 |
$1,440,000 |
|
Directors & Management
Data provided by Morningstar.
Name |
Title |
StartDate |
Profile |
Mr Alan David Fisher |
Non-Executive Director |
Sep 2016 |
|
Mr Aaron Weaver |
Non-Executive Director |
Jul 2020 |
|
Dr Errol De Souza |
Executive Chairman,Executive Director |
Aug 2016 |
|
Mr David Ian Wilson |
Non-Executive Director |
Jun 2016 |
|
Dr Jane Ryan |
Non-Executive Director |
Sep 2020 |
|
Mr Mitchell D Kaye |
Non-Executive Director |
Nov 2018 |
|
Dr Srinivas Rao |
Non-Executive Director |
Sep 2020 |
|
Mr Jack Moschakis |
Company Secretary,Legal Councel |
May 2015 |
|
Adrian Hinton |
Chief Financial Officer |
|
|
Jack Moschakis |
Company Secretary,Legal Councel |
|
|
Show more
Top Share Holders
Data provided by Morningstar.
Name |
Shares |
Capital |
N/A |
0 |
0.00% |